Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Affymetrix Inc.
Center for Inherited Disease Research Adds Affymetrix Platform for Large-Scale Genotyping Services
July 11th, 2008
Affymetrix Inc. (Nasdaq:AFFX) announced that the Center for Inherited Disease Research (CIDR) has adopted its Genome-Wide Human SNP Array 6.0 for large-scale genotyping and copy number projects. CIDR is making Affymetrix-based genotyping available to supporting members of the National Institutes of Health (NIH). The first study to take advantage of this new CIDR offering is a NIDDK-funded project to identify the genetic causes of type 2 diabetes in African-Americans. Donald W. Bowden, Ph.D. is director of the Wake Forest University School of Medicine Diabetes Center and the principal investigator of the study. His team will examine more than 2,200 samples in its first...
Source: Health Business Week (2008-07-11)
|
